Squarepoint
ASMB icon

Squarepoint’s Assembly Biosciences ASMB Stock Holding History

Squarepoint’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$940K Buy
34,214
+10,410
+44% +$283K ﹤0.01% 2941
2026
Q1 		$661K Buy
+23,804
New +$679K ﹤0.01% 3112
2025
Q2 		– Sell
-18,982
Closed -$181K – 4471
2025
Q1 		$181K Buy
+18,982
New +$248K ﹤0.01% 4048
2023
Q1 		– Sell
-874
Closed -$13.6K – 3211
2022
Q4 		$13.6K Buy
+874
New +$14.9K ﹤0.01% 3115
2022
Q1 		– Sell
-1,112
Closed -$31K – 2793
2021
Q4 		$31K Buy
+1,112
New +$36.5K ﹤0.01% 3069
2021
Q2 		– Sell
-2,883
Closed -$159K – 3208
2021
Q1 		$159K Sell
2,883
-806
-22% -$53.4K ﹤0.01% 2776
2020
Q4 		$268K Buy
3,689
+2,216
+150% +$260K ﹤0.01% 2293
2020
Q3 		$291K Buy
1,473
+395
+37% +$99.5K ﹤0.01% 1819
2020
Q2 		$302K Buy
+1,078
New +$252K ﹤0.01% 1600
2020
Q1 		– Sell
-3,577
Closed -$878K – 1849
2019
Q4 		$878K Sell
3,577
-1,328
-27% -$245K 0.01% 1416
2019
Q3 		$579K Buy
4,905
+3,480
+244% +$526K 0.01% 1535
2019
Q2 		$231K Buy
+1,425
New +$271K ﹤0.01% 2052
2019
Q1 		– Sell
-2,186
Closed -$593K – 2128
2018
Q4 		$593K Buy
2,186
+1,526
+231% +$441K 0.01% 1161
2018
Q3 		$294K Buy
660
+227
+52% +$106K ﹤0.01% 1549
2018
Q2 		$204K Buy
+433
New +$229K ﹤0.01% 1537
2018
Q1 		– Sell
-692
Closed -$376K – 1672
2017
Q4 		$376K Buy
+692
New +$313K 0.01% 1362

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Squarepoint's ASMB Position: Q2 2026 in Review

Squarepoint increased its Assembly Biosciences (ASMB) stake by 44% in Q2 2026, buying an estimated $283K and bringing the position to 34,214 shares worth $940K. The position accounts for ﹤0.01% of the portfolio, ranked #2941.

Squarepoint first reported a position in ASMB in Q4 2017 and has held it in 16 quarters since. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Squarepoint held 34,214 shares of Assembly Biosciences worth $940K as of Q2 2026.
  • Squarepoint bought 10,410 Assembly Biosciences shares in Q2 2026, an estimated $283K.
  • Assembly Biosciences made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2941 holding.
  • Squarepoint first reported a position in Assembly Biosciences in Q4 2017 and has held it in 16 quarters since.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.